Long-term outcomes of transoral incisionless fundoplication for gastro-esophageal reflux disease: systematic-review and meta-analysis.
Ontology highlight
ABSTRACT: Background and study aims? Few reports exist about long-term outcomes of transoral incisionless fundoplication (TIF) for treating refractory gastro-esophageal reflux disease (GERD). Methods? A literature search of four major scientific databases was performed up to May 2020 for studies reporting on more than 3-year outcomes of TIF. Data on atient satisfaction, proton pump inhibitor (PPI) daily consumption, PPI use reduction, GERD health-related quality-of-life (GERD-HRQL) score, and normalization of heartburn and regurgitation scores were pooled and summarized with forest plots. Publication bias and heterogeneity were explored. Results? Overall, eight studies (418 patients, 232 men; 55.5?%) with a mean follow-up of 5.3 years (range: 3-10 years) were included. The pooled proportion of patient-reported satisfaction before and after TIF was 12.3?% (95?% CI:12.3-35.1?%, I 2 ?=?87.4?%) and 70.6?% (95?% CI:51.2-84.6, I 2 ?=?80?%), respectively, corresponding to an odds ratio of 21.4 (95?% CI:3.27-140.5). Pooled rates of patients completely off PPIs and on occasional PPIs were 53.8?% (95?%CI: 42.0?%-65.1?%) and 75.8?% (95?%CI: 67.6-82.6), respectively. The pooled estimated mean GERD-HRQL scores off PPI before and after TIF werey 26.1 (95?%CI: 21.5-30.7; range: 20.0-35.5) and 5.9, respectively (95?%CI:0.35.1-11.4; range: 5.3-9.8; P ?Conclusion? Our study shows that TIF appears to offer a long-term safe therapeutic option for selected patients with GERD who refuse life-long medical therapy or surgery, are intolerant to PPIs, or are at increased surgical risk.
SUBMITTER: Testoni S
PROVIDER: S-EPMC7857958 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA